全球阿维A市场，按类型（品牌、仿制药）、应用（牛皮癣、实体器官移植、毛囊角化病、毛发红糠疹 (PRP)、鱼鳞病、格罗弗病（短暂性棘层松解性皮肤病）、扁平苔藓、红斑狼疮）、剂量（10 毫克、25 毫克、50 毫克）、最终用户（皮肤科诊所、专科诊所、医院、门诊手术中心、其他）、分销渠道（直接招标、医院药房、零售药房、网上药房、其他）划分 – 行业趋势和预测到 2031 年。
阿维A市场分析和规模
阿维A是一种类视黄酸药物，活性与维生素A相似。阿维A是一种水溶性药物，在脂肪组织中的沉积相对较少。FDA已批准阿维A用于治疗银屑病，包括全身性脓疱性银屑病、局限性脓疱性银屑病和严重斑块性银屑病等。它既可以作为单一疗法使用，也可以与UVB（紫外线B）、补骨脂素紫外线A（PUVA）、环孢菌素联合使用，也可以与生物疗法联合使用。
Data Bridge Market Research 分析，全球阿维A市场规模在 2023 年为 3135 万美元，到 2031 年将达到 4458 万美元，预计在预测期内的复合年增长率为 11.20%。由于对仿制药的需求不断增长，“仿制药”在全球阿维A市场类型细分中占据主导地位。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
阿维A市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（品牌药、仿制药）、应用（牛皮癣、实体器官移植、达里尔病、毛发红糠疹 (PRP)、鱼鳞病、格罗弗病（短暂性棘层松解性皮肤病）、扁平苔藓、红斑狼疮）、剂量（10 毫克、25 毫克、50 毫克）、最终用户（皮肤科诊所、专科诊所、医院、门诊手术中心、其他）、分销渠道（直接招标、医院药房、零售药房、网上药房、其他） |
|
覆盖国家 |
美国、加拿大、墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷、南美洲其他地区 |
|
涵盖的市场参与者 |
Biophore India Pharmaceuticals Pvt Ltd (India), Hangzhou Jinlan Pharmaceutical Technology Development Co., Ltd (China), Glopec International Inc. (Canada), Sun Pharma Industries Limited (India), Chongqing Huapont Pharmaceutical Co., Ltd. (China), SGPharma Pvt Ltd(India), AvKARE, LLC.(U.S.), Merck KGaA (Germany), Stiefel Laboratories Inc.(U.S.), Sionc Pharmaceuticals Pvt Ltd.(India0, Prasco Laboratories (U.S.), and Teva Pharmaceuticals USA, Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Acitretin, a retinoid, is a form of vitamin A. It is a second generation antipsoriatic drug. It is a prescription drug mainly applied to treat the psoriasis disease. It is long term use drug. It is found commonly in capsule type. It is not a principal cure for psoriasis and may result in relapse after medication termination. It may have side effects, such as severe congenital disabilities in pregnant females and severe liver problems.
Acitretin Market Dynamics
Drivers
- Increasing Prevalence of Psoriasis
The primary indication for acitretin is the treatment of severe psoriasis. As the prevalence of psoriasis continues to rise globally, the demand for effective treatment options, including acitretin, is likely to increase. Factors such as lifestyle changes, environmental factors, and genetic predisposition contribute to the growing incidence of psoriasis.
- Advancements in Psoriasis Treatment
Ongoing research and development activities in the field of dermatology and autoimmune diseases may lead to the introduction of new and improved treatment options for psoriasis. If acitretin demonstrates efficacy and safety compared to other treatment modalities, it could drive its adoption and market growth.
- Increasing Awareness and Diagnosis
Greater awareness about psoriasis and its impact on patients' quality of life may lead to increased diagnosis rates. As healthcare professionals and patients become more informed, there could be a higher demand for pharmacological interventions like acitretin, particularly in cases where other treatment options have proven ineffective or have undesirable side effects.
- Growing Investment for Healthcare Facilities
Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
- Expansion of Indications
Investigating and obtaining approvals for new indications of acitretin beyond its current use in severe psoriasis could present a significant opportunity. Clinical trials exploring the efficacy of acitretin in treating related dermatological conditions or autoimmune disorders might open up new markets and increase the overall demand for the medication.
- Growing Collaborations and Partnerships
Collaborations with research institutions, academic centers, and other pharmaceutical companies can accelerate the development and commercialization of acitretin. Partnering with organizations working on complementary therapies or diagnostic tools for psoriasis may create synergies and provide a more comprehensive solution for patients. Additionally, collaborations can help share development costs and risks.
Restraints
- Stringent Regulatory Requirements
Regulatory requirements, especially concerning safety and efficacy, can pose challenges for the development, approval, and commercialization of acitretin. Meeting stringent regulatory standards may involve significant time and financial investments. Changes in regulatory guidelines or requirements can also impact the market dynamics, affecting the availability and accessibility of acitretin in certain regions.
- Generic Competition
As patents expire, the entry of generic versions of acitretin into the market can lead to increased competition and potential price erosion. Generic alternatives may offer cost savings for patients and healthcare systems, impacting the market share and revenue potential for the branded version of acitretin. Manufacturers may need to employ strategies to differentiate their product and maintain a competitive edge.
Challenges
- Side Effects and Safety Concerns
Acitretin, like many medications, is associated with side effects, including mucocutaneous effects, teratogenicity, and lipid metabolism abnormalities. Concerns related to these side effects may limit its use, especially in certain patient populations. Safety considerations and the need for careful monitoring may pose challenges to widespread adoption, particularly for individuals with reproductive potential.
- Availability of Alternative Therapies
The pharmaceutical landscape for psoriasis and related dermatological conditions offers a variety of treatment options, including topical agents, phototherapy, and biologic therapies. The availability of alternative and often more targeted treatments may impact the market for acitretin, as healthcare providers and patients may opt for therapies with potentially fewer side effects or faster onset of action.
This acitretin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the acitretin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In May 2020, Allergen plc, a manufacturer of the acitretin drug was acquired and merged into AbbVie Inc. This helped to develop the service of production and distribution of the drug acitretin
- In April 2018, a Pediatric pharmacy advocacy group published about the unique preparation and delivery method for Acitretin for neonatal harlequin ichthyosis. No authors were found to be in conflict about the manuscripts, products, grants, and medication
Global Acitretin Market Scope
The acitretin market is segmented on the basis of product type, dose strength, distribution channel, application, and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Branded
- Generics
Dose Strength
- 10mg
- 25mg
- 50mg
Application
- Psoriasis
- Solid Organ Transplants
- Darier Disease
- Pityriasis Rubra Pilaris (PRP)
- Ichthyoses
- Grover Disease (Transient Acantholytic Dermatosis)
- Lichen Planus
- Lupus Erythematosus
End-Users
- Dermatology clinics
- Specialty clinics
- Hospital Pharmacy
- Ambulatory Surgical Centre
- Others
Distribution Channel
- Direct Tende
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Acitretin Market Regional Analysis/Insights
The acitretin market is analysed and market size insights and trends are provided by country, product type, dose strength, distribution channel, application, and end-users as referenced above.
The countries covered in the acitretin market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the global acitretin market because of the strong base of healthcare facilities, the strong presence of major players in the market, increased cases of surgical procedures among athletes, and the rising number of research activities in this region.
预计亚太地区将在预测期内出现显著增长，原因是政府加大了宣传力度，医疗旅游业蓬勃发展，该地区的研究活动日益增多，有大量未开发的市场，人口众多，以及对优质医疗服务的需求日益增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
阿维A市场还为您提供每个国家/地区资本设备医疗支出增长、阿维A市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对阿维A市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。
竞争格局和阿维A市场份额分析
阿维A市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
阿维A市场的一些主要参与者包括：
- Biophore India Pharmaceuticals Pvt Ltd（印度）
- 杭州金兰医药科技开发有限公司 (中国)
- Glopec International Inc.（加拿大）
- 太阳制药工业有限公司 (印度)
- 重庆华邦药业有限公司 (中国)
- SGPharma Pvt Ltd（印度）
- AvKARE, LLC.（美国）
- 默克集团（德国）
- Stiefel Laboratories Inc.（美国）
- Sionc Pharmaceuticals Pvt Ltd.（印度）
- Prasco Laboratories（美国），
- Teva Pharmaceuticals USA, Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
